Drug Manufacturers Challenge Abortion Pill Mailing Ban
Topics
Developing
- 862d Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore.
- 862d Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.
- 862d Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est.
- 862d Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium.
Sources · 7 independent
“Pharmaceutical company asks the U.S. Supreme Court to lift a lower court ruling that blocks health providers from sending the abortion pill mifepristone by mail.”
“Das Gericht hob Lockerungen der Arzneimittelbehörde FDA auf, mit einem Urteil, das im ganzen Land gilt. Der Pharmahersteller Denkro Laboratories beantragte unterdessen, mit einem Eilantrag an das oberste Gericht, das Urteil der niedrigen Instanz vorerst zu stoppen.”
“Makers of the abortion pill Mifepristone have directly asked the U.S. Supreme Court to allow the drug to remain available through telemedicine.”
“Makers of the abortion pill Mifepristone have directly asked the U.S. Supreme Court to allow the drug to remain available through telemedicine.”
“Makers of mifepristone are challenging a telemedicine ban. The ban restricts access to the abortion pill.”
“Mifepristone makers challenge telemedicine ban”
“The drug industry is fighting a controversial ruling on the abortion pill. The companies that produce Mifepristone are asking the Supreme Court to lift a lower federal appeals court ruling prohibiting health providers from prescribing the medication by mail.”
Unlock the full story
Get a Pro subscription or above to see the live story progression and the full list of independent sources confirming each event as they happen.
Log in to upgrade